Lv31
230 积分 2024-03-14 加入
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
1小时前
待确认
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older
16天前
已完结
Of Mice and Not Men: Differences between Mouse and Human Immunology
17天前
已完结
Safety and Immunogenicity of Nonadjuvanted and MF59-Adjuvanted Influenza A/H9N2 Vaccine Preparations
23天前
已完结
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®
23天前
已完结
The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice
24天前
已完结
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
24天前
已完结
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice
24天前
已完结
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
26天前
已完结
Treatment of experimentally induced benign prostatic hyperplasia with Tadalafil and castration in dogs
27天前
已完结
皖公网安备34019202002308
